Targeted drug duo challenges standard chemo in advanced breast cancer fight
NCT ID NCT07371910
Summary
This study compares a new approach using two targeted oral medications against standard chemotherapy for advanced breast cancer that has specific genetic features. After initial chemotherapy, half the participants switch to the targeted drug combination as long-term maintenance therapy, while the other half continue with standard treatments. Researchers want to see if this new strategy helps control the cancer longer and improves survival for patients who have already tried some treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510030, China
Conditions
Explore the condition pages connected to this study.